Background Inhaled corticosteroids (ICS) are anti‐inflammatory drugs that have proven
benefits for people with worsening symptoms of chronic obstructive pulmonary disease …

Background The overlap between asthma and COPD is increasingly recognised. This
review examines the new insights, treatment and remaining knowledge gaps for asthma …

The relevance of the ACOS is to identify patients with COPD who may have underlying
eosinophilic inflammation that responds to inhaled corticosteroids. So far, the previous …

Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a
network meta‐analysis - Kew, KM - 2014 | Cochrane Library Skip to Content Cookies Our site …

Rationale: Detailed characterization of asthma phenotypes is essential for identification of
responder populations to allow directed personalized medical intervention. Objectives: The …

SETTING: Clinical phenotypes of chronic obstructive pulmonary disease (COPD) identify
patients with common characteristics. OBJECTIVES: To investigate the distribution of four …

Background Some patients share characteristics of both COPD and asthma. As yet, there is
no gold standard to identify patients with the so-called asthma–COPD overlap syndrome …

Chronic obstructive pulmonary disease (COPD) is characterized by persistent airflow
limitation, the severity of which is assessed using forced expiratory volume in 1 sec (FEV1 …

Background The traditional classification of COPD, which relies solely on spirometry, fails to
account for the complexity and heterogeneity of the disease. Phenotyping is a method that …

Background Patients with chronic obstructive pulmonary disease (COPD) are at risk of
exacerbations and pneumonia; how the risk factors interact is unclear. Methods This post …